Ligocyte - News Articles

	Date: 3/18/2008 LIGOCYTE PHARMACEUTICALS FINALIZES AGREEMENT FOR $28M SERIES “C” FINANCING ROUND SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 9/18/2007 LIGOCYTE PHARMACEUTICALS ANNOUNCES COLLABORATION WITH BIOGEN IDEC TO DEVELOP ANTI-CD103 THERAPIES SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 5/1/2007 LIGOCYTE PHARMACEUTICALS PRESENTS DATA SHOWING HETEROSUBTYPIC PROTECTION AGAINST INFLUENZA CHALLENGE WITH VIRUS-LIKE PARTICLE IMMUNIZATION SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 4/18/2007 LIGOCYTE PHARMACEUTICALS WINS SMALL BUSINESS OF THE YEAR AWARD SOURCE: LigoCyte Pharmaceuticals & Prospera Business Network
	Date: 4/3/2007 LIGOCYTE PHARMACEUTICALS INITIATES U.S. CLINICAL TRIAL OF NOROVIRUS VACCINE SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 1/3/2007 DONALD P. BEEMAN IS APPOINTED CHAIRMAN OF THE BOARD OF DIRECTORS AT LIGOCYTE PHARMACEUTICALS, INC. SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 12/14/2006 LIGOCYTE PHARMACEUTICALS ANNOUNCES THE ADDITION OF DR. DONALD DEBETHIZY TO THEIR BOARD OF DIRECTORS SOURCE: LigoCyte Pharmaceuticals, Inc,
	Date: 5/18/2006 LIGOCYTE PHARMACEUTICALS WELCOMES DON BEEMAN AS NEW CEO Source: LigoCyte Pharmaceuticals, Inc.
	Date: 10/3/2005 LIGOCYTE PHARMACEUTICALS RECEIVES $4.6M NIH BIODEFENSE CHALLENGE GRANT FOR INTRANASAL ANTHRAX VACCINE Source: LigoCyte Pharmaceuticals, Inc.
	Date: 5/16/2005 LIGOCYTE MOVES INTO SPACIOUS NEW BUILDING TO ACCOMODATE GROWTH Source: Bozeman Daily Chronicle
	Date: 3/21/2005 LIGOCYTE PRESENTS DATA SHOWING PROTECTION FROM IMPROVED ANTHRAX VACCINE AT THE ASM BIODEFENSE MEETING Source: LigoCyte Pharmaceuticals, Inc.
	Date: 11/18/2004 NEW ALLIANCE PROMOTES MONTANA BIOTECH INDUSTRY Source: Bozeman Daily Chronicle
	Date: 6/25/2004 LIGOCYTE AWARDED ADDITIONAL $2.1M DEPARTMENT OF DEFENSE CONTRACT FOR THE DEVELOPMENT OF NOROVIRUS VACCINE SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 6/11/2004 LIGOCYTE PHARMACEUTICALS RECEIVES MONTANA BOARD OF RESEARCH AND COMMERCIAL TECHNOLOGY GRANT TO DEVELOP NOVEL TRANSFECTION REAGENT SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 5/25/2004 LIGOCYTE PHARMACEUTICALS EXECUTES NOROVIRUS VACCINE AGREEMENT WITH BAYLOR COLLEGE OF MEDICINE SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 5/5/2004 LIGOCYTE PHARMACEUTICALS RECEIVES ADDITIONAL $3.6M DEPARTMENT OF DEFENSE CONTRACT FOR MUCOSAL ANTHRAX VACCINE DEVELOPMENT SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 5/3/2004 LIGOCYTE PHARMACEUTICALS APPOINTS MARK MCDADE, WILLIAM G. LITTLE AND JOHN TOMLIN TO BOARD OF DIRECTORS SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 1/11/2004 MSU GETS $10.5 MILLION TO FIND BIOTERROR DRUGS - FAST SOURCE: Gail Schontzler, Chronicle Staff Writer
	Date: 1/5/2004 CHARLES RICHARDSON JOINS LIGOCYTE PHARMACEUTICALS AS SENIOR VICE PRESIDENT, RESEARCH AND DEVELOPMENT SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 11/26/2003 LIGOCYTE PLANS NEW BUILDING SOURCE: Bozeman Daily Chronicle
	Date: 10/5/2003 UNIVERSITY PARTNERSHIP HELPS LIGOCYTE SCORE FEDERAL FUNDS SOURCE: Bozeman Daily Chronicle
	Date: 8/4/2003 ABBOTT LABORATORIES AND LIGOCYTE PHARMACEUTICALS ANNOUNCE RESEARCH COLLABORATION FOR MONOCLONAL ANTIBODY SOURCE: Abbott Laboratories
	Date: 6/17/2003 LIGOCYTE LICENSES KEY PATENT FROM THE CENTER FOR BLOOD RESEARCH SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 7/11/2002 HOMELAND SECURITY EXPO ATTENDED BY BOZEMAN COMPANIES LIGOCYTE AND SCIENTIFIC MATERIALS SOURCE: Kayley Mendenhall, Chronicle Staff Writer
	Date: 10/18/2001 LIGOCYTE PARTICIPATES IN KENNEDY ROUND TABLE MEETING ON BIOTERRORISM SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 9/18/2001 LIGOCYTE PHARMACEUTICALS ANNOUNCES A COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH THE NATIONAL INSTITUTES OF HEALTH FOR MUCOSAL RABIES VACCINE SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 5/7/2001 LIGOCYTE ANNOUNCES KATE McKEREGHAN, CORIXA GENERAL COUNSEL, ELECTED TO BOARD OF DIRECTORS SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 3/6/2001 LIGOCYTE REPORTS DATA ON ANTI-INFECTIVE DRUG DISCOVERY TECHNOLOGIES SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 12/7/2000 LIGOCYTE TO DEVELOP MSU VACCINE TECHNOLOGY FOR ORAL/NASAL DELIVERY OF ANTI-INFECTIVE AGENTS SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 10/3/2000 LIGOCYTE RECEIVES “TIBBETTS AWARD” FOR EXCELLENCE IN THE SMALL BUSINESS INNOVATION RESEARCH PROGRAM SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 9/22/2000 VACCINE PIONEER AND MILES CITY NATIVE RETURNS TO MONTANA FOR LECTURE SOURCE: Annette Trinity-Steven, MSU Research Editor
	Date: 9/18/2000 DR. MAURICE HILLEMAN TO LAUNCH THE LIGOCYTE LECTURE SERIES AT MONTANA STATE UNIVERSITY SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 5/1/2000 LIGOCYTE RECEIVES $2.8 MILLION NIH PHASE II SBIR GRANT TO DEVELOP ITS NANOPARTICLE TECHNOLOGY FOR INFLAMMATORY DISEASES SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 10/27/1999 LIGOCYTE TO RECEIVE 1.5 MILLION IN FEDERAL FUNDING FOR RESEARCH FROM THE DEPARTMENT OF DEFENSE SOURCE: LigoCyte Pharmaceuticals, Inc.
	Date: 10/14/1999 DEFENSE FUNDS PASS FINAL SENATE VOTE MONTANA ON TRACK FOR MORE THAN $28 MILLION IN DEFENSE FUNDS FOR FY 2000 SOURCE: Montana Senator Conrad Burns
	Date: 10/7/1999 LIGOCYTE AND CORIXA FORM COLLABORATION TO DEVELOP AND DISTRIBUTE CANDIDA PRODUCTS SOURCE: Corixa Corporation
	Date: 7/16/1999 SPACE SHUTTLE CONTAINS LOCAL EXPERIMENT SOURCE: Montana Senator Conrad Burns
	Date: 2/1/1999 NEW GENERATION OF THERAPEUTICS ANCHORED BY BIOADHESION LigoCyte Pharmaceuticals, Inc. – Carol Potera